UniProt ID | UBP15_MOUSE | |
---|---|---|
UniProt AC | Q8R5H1 | |
Protein Name | Ubiquitin carboxyl-terminal hydrolase 15 | |
Gene Name | Usp15 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 981 | |
Subcellular Localization | Cytoplasm . Nucleus . Mitochondrion . | |
Protein Description | Hydrolase that removes conjugated ubiquitin from target proteins and regulates various pathways such as the TGF-beta receptor signaling, NF-kappa-B and RNF41/NRDP1-PRKN pathways. Acts as a key regulator of TGF-beta receptor signaling pathway, but the precise mechanism is still unclear: according to a report, acts by promoting deubiquitination of monoubiquitinated R-SMADs (SMAD1, SMAD2 and/or SMAD3), thereby alleviating inhibition of R-SMADs and promoting activation of TGF-beta target genes. According to another reports, regulates the TGF-beta receptor signaling pathway by mediating deubiquitination and stabilization of TGFBR1, leading to an enhanced TGF-beta signal. Able to mediate deubiquitination of monoubiquitinated substrates as well as 'Lys-48'-linked polyubiquitin chains, protecting them against proteasomal degradation. May also regulate gene expression and/or DNA repair through the deubiquitination of histone H2B. Acts as an inhibitor of mitophagy by counteracting the action of parkin (PRKN): hydrolyzes cleavage of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains attached by parkin on target proteins such as MFN2, thereby reducing parkin's ability to drive mitophagy. Acts as an associated component of COP9 signalosome complex (CSN) and regulates different pathways via this association: regulates NF-kappa-B by mediating deubiquitination of NFKBIA and deubiquitinates substrates bound to VCP. Involved in endosome organization by mediating deubiquitination of SQSTM1: ubiquitinated SQSTM1 forms a molecular bridge that restrains cognate vesicles in the perinuclear region and its deubiquitination releases target vesicles for fast transport into the cell periphery.. | |
Protein Sequence | MAEGGAADLDTQRSDIATLLKTSLRKGDTWYLVDSRWFKQWKKYVGFDSWDKYQMGDQNVYPGPIDNSGLLKDGDAQSLKEHLIDELDYILLPTEGWNKLVSWYTLMEGQEPIARKVVEQGMFVKHCKVEVYLTELKLCENGNMNNVVTRRFSKADTIDTIEKEIRKIFNIPDEKEARLWNKYMSNTFEPLNKPDSTIQDAGLYQGQVLVIEQKNEDGTWPRGPSTPKSPGASNFSTLPKISPSSLSNNYNNINNRNVKNSNYCLPSYTAYKNYDYSEPGRNNEQPGLCGLSNLGNTCFMNSAIQCLSNTPPLTEYFLNDKYQEELNFDNPLGMRGEIAKSYAELIKQMWSGKFSYVTPRAFKTQVGRFAPQFSGYQQQDCQELLAFLLDGLHEDLNRIRKKPYIQLKDADGRPDKVVAEEAWENHLKRNDSIIVDIFHGLFKSTLVCPECAKISVTFDPFCYLTLPLPMKKERSLEVYLVRMDPLAKPMQYKVIVPKIGNILDLCTALSALSGVPADKMIVTDIYNHRFHRIFAVDENLSSIMERDDIYVFEININRAEDTEHVVIPVCLREKFRHSSYTHHTGSSLFGQPFLMAIPRNNTEDKLYNLLLLRMCRYVKMSTETEETDGHLRCCEDQNINGNGPNGLHEEGSPSEMETDEPDDESSQDQELPSENENSQSEDSVGGDNDSENGLCTEETCKGQLTGHKKRLFTFQFNNLGNNDINYIKDDTSHIRFDDRQLRLDERSFLALDWDPDLKKRYFDENAAEDFEKHESVEYKPPKRPFVKLKDCIELFTTKEKLGAEDPWYCPNCKEHQQATKKLDLWSLPPVLVVHLKRFSYSRYMRDKLDTLVDFPISDLDMSEFLINPNAGPCRYNLIAVSNHYGGMGGGHYTAFAKNKDDGKWYYFDDSSVSTASEDQIVSKAAYVLFYQRQDTFSGTGFFPLDRETKGASAATGIPLESDEDSNDNDNDLENENCMHTN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAEGGAADL ------CCCCCCCCC | 24.92 | - | |
154 | Ubiquitination | VVTRRFSKADTIDTI CEEECCCCCCCHHHH | 47.79 | 22790023 | |
193 | Ubiquitination | NTFEPLNKPDSTIQD CCCCCCCCCCCCCCC | 58.86 | 22790023 | |
219 | Phosphorylation | EQKNEDGTWPRGPST EEECCCCCCCCCCCC | 44.62 | - | |
225 | Phosphorylation | GTWPRGPSTPKSPGA CCCCCCCCCCCCCCC | 61.23 | 22942356 | |
225 (in isoform 5) | Phosphorylation | - | 61.23 | 23375375 | |
226 (in isoform 5) | Phosphorylation | - | 37.56 | 25263469 | |
226 (in isoform 2) | Phosphorylation | - | 37.56 | 23375375 | |
226 | Phosphorylation | TWPRGPSTPKSPGAS CCCCCCCCCCCCCCC | 37.56 | 26824392 | |
227 (in isoform 2) | Phosphorylation | - | 39.19 | 25263469 | |
228 | Ubiquitination | PRGPSTPKSPGASNF CCCCCCCCCCCCCCC | 70.17 | 22790023 | |
229 | Phosphorylation | RGPSTPKSPGASNFS CCCCCCCCCCCCCCC | 29.75 | 26824392 | |
231 (in isoform 2) | Ubiquitination | - | 49.05 | - | |
233 | Phosphorylation | TPKSPGASNFSTLPK CCCCCCCCCCCCCCC | 44.30 | 25521595 | |
234 (in isoform 5) | Phosphorylation | - | 34.06 | 29514104 | |
235 (in isoform 2) | Phosphorylation | - | 5.67 | 29514104 | |
236 | Phosphorylation | SPGASNFSTLPKISP CCCCCCCCCCCCCCH | 33.03 | 25619855 | |
237 | Phosphorylation | PGASNFSTLPKISPS CCCCCCCCCCCCCHH | 42.83 | 25619855 | |
242 | Phosphorylation | FSTLPKISPSSLSNN CCCCCCCCHHHCCCC | 25.51 | 26824392 | |
244 | Phosphorylation | TLPKISPSSLSNNYN CCCCCCHHHCCCCCC | 36.80 | 25168779 | |
245 | Phosphorylation | LPKISPSSLSNNYNN CCCCCHHHCCCCCCC | 38.92 | 25619855 | |
247 | Phosphorylation | KISPSSLSNNYNNIN CCCHHHCCCCCCCCC | 25.61 | 25619855 | |
250 | Phosphorylation | PSSLSNNYNNINNRN HHHCCCCCCCCCCCC | 17.52 | 25619855 | |
259 | Ubiquitination | NINNRNVKNSNYCLP CCCCCCCCCCCCCCC | 59.20 | 22790023 | |
263 | Phosphorylation | RNVKNSNYCLPSYTA CCCCCCCCCCCCCCE | 8.66 | 29514104 | |
274 | Phosphorylation | SYTAYKNYDYSEPGR CCCEECCCCCCCCCC | 16.47 | 25367039 | |
276 | Phosphorylation | TAYKNYDYSEPGRNN CEECCCCCCCCCCCC | 12.46 | 25367039 | |
363 | Ubiquitination | YVTPRAFKTQVGRFA EECCHHHHHCCCCCC | 36.74 | 22790023 | |
541 | Phosphorylation | FAVDENLSSIMERDD EEECCCHHHHHHHCC | 29.42 | 23984901 | |
542 | Phosphorylation | AVDENLSSIMERDDI EECCCHHHHHHHCCE | 29.17 | 23984901 | |
562 | Phosphorylation | NINRAEDTEHVVIPV EEECCCCCCCEEEEE | 21.35 | - | |
602 | Phosphorylation | MAIPRNNTEDKLYNL EEECCCCCHHHHHHH | 49.46 | 22817900 | |
605 | Ubiquitination | PRNNTEDKLYNLLLL CCCCCHHHHHHHHHH | 46.79 | 22790023 | |
607 | Phosphorylation | NNTEDKLYNLLLLRM CCCHHHHHHHHHHHH | 14.98 | 25168779 | |
621 | Phosphorylation | MCRYVKMSTETEETD HHHHHCCCCCCCCCC | 19.85 | 22817900 | |
622 | Phosphorylation | CRYVKMSTETEETDG HHHHCCCCCCCCCCC | 43.35 | 20415495 | |
624 | Phosphorylation | YVKMSTETEETDGHL HHCCCCCCCCCCCCE | 38.93 | 20415495 | |
627 | Phosphorylation | MSTETEETDGHLRCC CCCCCCCCCCCEEEC | 40.84 | 20415495 | |
696 | Phosphorylation | DSENGLCTEETCKGQ CCCCCCCCCHHHCCC | 41.73 | - | |
699 | Phosphorylation | NGLCTEETCKGQLTG CCCCCCHHHCCCCCC | 17.18 | - | |
705 | Phosphorylation | ETCKGQLTGHKKRLF HHHCCCCCCCCCEEE | 29.38 | - | |
758 | Ubiquitination | LDWDPDLKKRYFDEN CCCCHHHHHHHCCCC | 42.45 | 22790023 | |
847 | Ubiquitination | YSRYMRDKLDTLVDF HHHHHHHHHCCCCCC | 37.59 | - | |
881 | Phosphorylation | RYNLIAVSNHYGGMG EEEEEEEECCCCCCC | 14.63 | - | |
952 | Phosphorylation | DRETKGASAATGIPL CCCCCCCCCCCCCCC | 27.40 | 25159016 | |
955 | Phosphorylation | TKGASAATGIPLESD CCCCCCCCCCCCCCC | 35.05 | 25521595 | |
961 | Phosphorylation | ATGIPLESDEDSNDN CCCCCCCCCCCCCCC | 54.72 | 25521595 | |
965 | Phosphorylation | PLESDEDSNDNDNDL CCCCCCCCCCCCCCC | 43.99 | 25521595 | |
980 | Phosphorylation | ENENCMHTN------ CCCCCCCCC------ | 0.00 | 25159016 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
678 | S | Phosphorylation | Kinase | ATM | Q62388 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UBP15_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBP15_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SART3_HUMAN | SART3 | physical | 24984263 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...